Innate Pharma
IPHA
#9113
Rank
A$0.18 B
Marketcap
A$1.97
Share price
2.92%
Change (1 day)
-37.37%
Change (1 year)

Half-year Reports

Thumbnail Innate Pharma
 Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2024-h1

Half-year Report 2024-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: French

View Half-year Report
Thumbnail Innate Pharma
 Half-year Report 2020-h1

Half-year Report 2020-h1

Language: French

View Half-year Report